159 related articles for article (PubMed ID: 34282595)
1. Predicting the Course of Graves' Orbitopathy Using Serially Measured TSH-Receptor Autoantibodies by Automated Binding Immunoassays and the Functional Bioassay.
Stöhr M; Oeverhaus M; Lytton SD; Horstmann M; Zwanziger D; Möller L; Stark A; Führer-Sakel D; Bechrakis N; Berchner-Pfannschmidt U; Banga JP; Philipp S; Eckstein A
Horm Metab Res; 2021 Jul; 53(7):435-443. PubMed ID: 34282595
[TBL] [Abstract][Full Text] [Related]
2. Predicting the Relapse of Hyperthyroidism in Treated Graves' Disease with Orbitopathy by Serial Measurements of TSH-Receptor Autoantibodies.
Stöhr M; Oeverhaus M; Lytton SD; Horstmann M; Zwanziger D; Möller L; Stark A; Führer-Sakel D; Bechrakis N; Berchner-Pfannschmidt U; Banga JP; Philipp S; Eckstein A
Horm Metab Res; 2021 Apr; 53(4):235-244. PubMed ID: 33618407
[TBL] [Abstract][Full Text] [Related]
3. Relevance of TSH-receptor antibody levels in predicting disease course in Graves' orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay.
Jang SY; Shin DY; Lee EJ; Lee SY; Yoon JS
Eye (Lond); 2013 Aug; 27(8):964-71. PubMed ID: 23743527
[TBL] [Abstract][Full Text] [Related]
4. Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy.
Nicolì F; Lanzolla G; Mantuano M; Ionni I; Mazzi B; Leo M; Sframeli A; Posarelli C; Maglionico MN; Figus M; Nardi M; Marcocci C; Marinò M
J Endocrinol Invest; 2021 Mar; 44(3):581-585. PubMed ID: 32648002
[TBL] [Abstract][Full Text] [Related]
5. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
Woo YJ; Jang SY; Lim TH; Yoon JS
Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the first fully automated immunoassay method for the measurement of stimulating TSH receptor autoantibodies in Graves' disease.
Tozzoli R; D'Aurizio F; Villalta D; Giovanella L
Clin Chem Lab Med; 2017 Jan; 55(1):58-64. PubMed ID: 27331310
[TBL] [Abstract][Full Text] [Related]
7. Functional diagnostics for thyrotropin hormone receptor autoantibodies: bioassays prevail over binding assays.
Lytton SD; Schluter A; Banga PJ
Front Biosci (Landmark Ed); 2018 Jun; 23(11):2028-2043. PubMed ID: 29772543
[TBL] [Abstract][Full Text] [Related]
8. Correlation between TSH receptor antibody assays and clinical manifestations of Graves' orbitopathy.
Jang SY; Shin DY; Lee EJ; Choi YJ; Lee SY; Yoon JS
Yonsei Med J; 2013 Jul; 54(4):1033-9. PubMed ID: 23709442
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
[TBL] [Abstract][Full Text] [Related]
10. Measurement of anti-TSH receptor antibodies: what is the correct cut-off value?
Smit MA; van Kinschot CMJ; van der Linden J; van Noord C; Kos S
Neth J Med; 2020 Mar; 78(2):55-63. PubMed ID: 32332174
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of Graves' orbitopathy in patients showing discrepancy between levels from TBII assays and TSI bioassay.
Jang SY; Shin DY; Lee EJ; Yoon JS
Clin Endocrinol (Oxf); 2014 Apr; 80(4):591-7. PubMed ID: 24033537
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease.
Eckstein AK; Plicht M; Lax H; Neuhäuser M; Mann K; Lederbogen S; Heckmann C; Esser J; Morgenthaler NG
J Clin Endocrinol Metab; 2006 Sep; 91(9):3464-70. PubMed ID: 16835285
[TBL] [Abstract][Full Text] [Related]
13. [Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology].
Eckstein A; Mann K; Kahaly GJ; Grussendorf M; Reiners C; Feldkamp J; Quadbeck B; Bockisch A; Schott M
Med Klin (Munich); 2009 May; 104(5):343-8. PubMed ID: 19444414
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of TSH receptor antibodies measurement in patients with Graves' orbitopathy.
Eckstein A; Esser J; Mann K; Schott M
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():198-203. PubMed ID: 20467363
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves' orbitopathy.
Park J; Kim J; Kim SS; Choi HY
Front Endocrinol (Lausanne); 2023; 14():1153312. PubMed ID: 37223049
[TBL] [Abstract][Full Text] [Related]
16. Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies.
Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; van Helden J; Inomata K; Jarausch J; Kratzsch J; Mann K; Miyazaki N; Navarro Moreno MA; Murakami T; Roth HJ; Noh JY; Scherbaum WA; Schott M
Clin Chim Acta; 2009 Mar; 401(1-2):84-9. PubMed ID: 19091299
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Five TSH-Receptor Antibody Assays in Graves' disease: results from an observational pilot study.
Struja T; Jutzi R; Imahorn N; Kaeslin M; Boesiger F; Kutz A; Mundwiler E; Huber A; Kraenzlin M; Mueller B; Meier C; Bernasconi L; Schuetz P
BMC Endocr Disord; 2019 Apr; 19(1):38. PubMed ID: 31023276
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of TSH receptor antibody levels in Graves' orbitopathy: a comparison of two TSH receptor antibody immunoassays.
Bluszcz GA; Bednarczuk T; Bartoszewicz Z; Kondracka A; Walczak K; Żurecka Z; Demkow U; Miśkiewicz P
Cent Eur J Immunol; 2018; 43(4):405-412. PubMed ID: 30799988
[TBL] [Abstract][Full Text] [Related]
19. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease.
Schott M; Morgenthaler NG; Fritzen R; Feldkamp J; Willenberg HS; Scherbaum WA; Seissler J
Horm Metab Res; 2004 Feb; 36(2):92-6. PubMed ID: 15002058
[TBL] [Abstract][Full Text] [Related]
20. Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy.
De Bellis A; Bizzarro A; Conte M; Coronella C; Solimeno S; Perrino S; Sansone D; Guaglione M; Wall JR; Bellastella A
Clin Endocrinol (Oxf); 2003 Sep; 59(3):388-95. PubMed ID: 12919164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
